Entera Bio
Entera Bio Logo
About Entera Bio
Entera Bio Ltd is a clinical-stage biotechnology company focused on developing oral peptide and protein replacement therapies for significant unmet medical needs. Leveraging its N-Tab oral delivery technology, Entera Bio develops tablet-based treatments designed to stabilize peptides in the gastrointestinal tract and enhance absorption. Its lead product candidates include EB613, an oral PTH (1-34) tablet for osteoporosis in postmenopausal women, and EB612, an oral PTH (1-34) tablet for hypoparathyroidism. The company is also advancing oral oxyntomodulin for obesity and oral GLP-2 for rare malabsorption conditions such as short bowel syndrome. Entera Bio was founded in 2009 and is based in Jerusalem, Israel.
Address
Kiryat Hadassah Minrav Building, Fifth Floor
Jerusalem, 9112002
Israel
Year founded
2009
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
